Hydroxychloroquine vs Tofacitinib
Hydroxychloroquine vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Hydroxychloroquine and Tofacitinib.
Mechanism of Action
Hydroxychloroquine: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Hydroxychloroquine β 40-50 days; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Hydroxychloroquine β C18H26ClN3O; Tofacitinib β C16H20N6O.
Molecular Weight: Hydroxychloroquine β 335.8720 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Hydroxychloroquine β Small molecule; Tofacitinib β Small molecule.